The deal provides an exit for AEA Investors and Thomas H. Lee, more than four years and six years into their investments, respectively.
3 min read · 23 September 2020
Dr. Eglen will work with Arsenal’s healthcare team to further develop life science tools and reagents investment themes.
2 min read · 23 September 2020
Customer concentration issues have weighed on the process for CareCentrix, a home- and post-acute care benefits manager backed by Summit Partners.
3 min read · 22 September 2020
Ellodi is developing a treatment of the eosinophilic esophagitis.
4 min read · 22 September 2020
TPG Capital will retain the rights to Adare's Eosinophilic Esophagitis (EoE) product, which has been spun out into a separate entity.
5 min read · 22 September 2020
Today, the company has annual revenues in excess of €460 million ($540 million) and 850 employees.
3 min read · 22 September 2020
MPE Partners will maintain a minority interest in the Trachte, which provides easy-deployment application-engineered protection and control buildings.
4 min read · 22 September 2020
Odyssey previously weighed buying ProPharma through existing portfolio company TrialCard, three sources said.
3 min read · 22 September 2020
If a deal is reached, existing investors Berkshire Partners and TPG Growth are expected to remain minority investors in the provider of outsourced pharma services.
2 min read · 21 September 2020
The Thurston Group, a healthcare-focused PE firm based in Chicago, also invested in the deal.
4 min read · 21 September 2020
